| 11/02/2026 8:46 PM | ARCH Venture Fund XIV, L.P. (2138046) Reporting ARCH Venture Partners XIV, L.P. (2147717) Reporting ARCH Venture Partners XIV, LLC (2148927) Reporting Aspen Neuroscience (2124080) Issuer BERNS PAUL L (1202769) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/02/2026 8:50 PM | ARCH Venture Fund X Overage, L.P. (1757017) Reporting ARCH Venture Fund X, L.P. (1757011) Reporting ARCH Venture Partners X Overage, L.P. (1768905) Reporting ARCH Venture Partners X, L.P. (1782583) Reporting ARCH Venture Partners X, LLC (1769012) Reporting Aspen Neuroscience (2124080) Issuer Burow Kristina (1569248) Reporting CRANDELL KEITH (1219039) Reporting GILLIS STEVEN (1229592) Reporting NELSEN ROBERT (1219042) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/02/2026 8:03 PM | Aspen Neuroscience (2124080) Issuer Hasnain Faheem (1352620) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/02/2026 8:05 PM | Aspen Neuroscience (2124080) Issuer Spaventa Andrew (1859701) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/02/2026 4:25 PM | Aspen Neuroscience (2124080) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 10/30/2026 3:38 PM | Aspen Neuroscience (2124080) Filer | Form 424B4 | |
| 10/29/2026 11:15 PM | Aspen Neuroscience (2124080) Filer | Form EFFECT | |
| 10/29/2026 7:29 PM | Aspen Neuroscience (2124080) Issuer ORBIMED ADVISORS LLC (1055951) Reporting OrbiMed Capital GP VII LLC (1760648) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/29/2026 7:14 PM | Aspen Neuroscience (2124080) Issuer Hasnain Faheem (1352620) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/29/2026 7:16 PM | Aspen Neuroscience (2124080) Issuer Spaventa Andrew (1859701) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/29/2026 7:24 PM | Aspen Neuroscience (2124080) Issuer Boerneke Jeffrey Lee (2162676) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for ASPE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aspen Neuroscience and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/29/2026 7:00 PM | Aspen Neuroscience (2124080) Issuer Fisher Douglas Carl (1572355) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/29/2026 7:04 PM | Aspen Neuroscience (2124080) Issuer McDevitt Damien (1742277) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/29/2026 7:05 PM | Aspen Neuroscience (2124080) Issuer Thompson Peter A. (1357522) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/29/2026 7:10 PM | Aspen Neuroscience (2124080) Issuer Daniel Thomas O (1538894) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/29/2026 7:11 PM | ARCH Venture Fund X Overage, L.P. (1757017) Reporting ARCH Venture Fund X, L.P. (1757011) Reporting ARCH Venture Partners X Overage, L.P. (1768905) Reporting ARCH Venture Partners X, L.P. (1782583) Reporting ARCH Venture Partners X, LLC (1769012) Reporting Aspen Neuroscience (2124080) Issuer Burow Kristina (1569248) Reporting CRANDELL KEITH (1219039) Reporting GILLIS STEVEN (1229592) Reporting NELSEN ROBERT (1219042) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/29/2026 6:47 PM | Aspen Neuroscience (2124080) Issuer Johnson-Pratt Lisa (1849760) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/29/2026 6:48 PM | Aspen Neuroscience (2124080) Issuer Raineri Kim (2162455) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/29/2026 6:55 PM | Aspen Neuroscience (2124080) Issuer Meeter Dalen (1859032) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/29/2026 6:57 PM | Aspen Neuroscience (2124080) Issuer Peterson Caryn (1857256) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/29/2026 6:40 PM | Aspen Neuroscience (2124080) Issuer Perettie Cynthia Dorothy (2162497) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/29/2026 11:03 AM | Aspen Neuroscience (2124080) Filer | Form CERT | |
| 10/29/2026 5:53 AM | Aspen Neuroscience (2124080) Filer | Form 8-A12B | |
| 10/26/2026 5:54 AM | Aspen Neuroscience (2124080) Filer | Form S-1/A | |
| 10/22/2026 6:00 AM | Aspen Neuroscience (2124080) Filer | Form S-1/A | |
| 10/09/2026 3:12 PM | Aspen Neuroscience (2124080) Filer | Form S-1 Registration statement under Securities Act of 1933 | |